GlassScriptPhysician profile
Ralph Eugene Massullo
NPI 1104810563
$5,037.51
in general payments reported to CMS, 2019-2025
16 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.33 · 2020: $1,559 · 2021: $2,694 · 2022: $124 · 2023: $140 · 2024: $235 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,127.82 | 2020-2024 | Sotyktu |
| Pfizer INC. | $1,000.00 | 2020 | |
| Abbvie INC. | $301.47 | 2021-2025 | |
| Smith+Nephew, INC. | $124.31 | 2020-2025 | Collagenase Santyl |
| Leo Pharma INC. | $121.28 | 2019-2025 | Anzupgo, Adbry |
| Novartis Pharmaceuticals Corporation | $75.62 | 2024-2025 | |
| Amgen INC. | $61.22 | 2025 | Otezla |
| Sensus Healthcare, INC. | $54.05 | 2021 | |
| Janssen Biotech, INC. | $36.48 | 2019-2023 | Tremfya |
| Galderma Laboratories, L.P. | $27.12 | 2019 | |
| Allergan, INC. | $24.76 | 2019 | |
| Lilly USA, LLC | $21.16 | 2024 | Ebglyss |
| Genzyme Corporation | $19.09 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.69 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.45 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $9.99 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Massullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.